By enabling more accurate cellular and animal models of pathological processes, genome editing is expanding the ability to elucidate the contribution of genetics to diagnostics.The introduction of the Cas-9 technique is the most significant advancement in this field. This is a game-changing breakthrough in biomedical research.
The use of CRISPR/Cas 9 focuses on somatic cell genome editing and aims to speed up treatment for a variety of genetic disorders. Furthermore, the COVID-19 pandemic is expected to find credible applications of this technique to understand the mutation of the novel coronavirus.The recent development of a flexible, democratized genome-engineering toolbox based on programmable targeting of CRISPR and Cas systems has been fueled by the discovery and characterization of CRISPR and Cas genes.
Increased funding for research activities to provide modified products for the prevention of chronic diseases is expected to drive the growth of the CRISPR and Cas genes market in North America. In the United States, a clinical trial to use CRISPR for disease treatment was launched in 2016. The demand for genetically engineered treatment options for chronic diseases such as cancer is expected to boost the market's growth prospects in the Asia Pacific.
Read more@ https://bit.ly/3Dr1jzy